Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Sep 1, 2026
Date Accepted: Oct 30, 2026

The final, peer-reviewed published version of this preprint can be found here:

Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial

Kuehn K, Moore R, Foster KT, Depp C

Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial

JMIR Res Protoc 2026;15:e109277

DOI: 10.2196/109277

PMID: 43050679

Development of PRECISE: A Data-Driven Personalized Suicide Prevention Intervention – Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial

  • Kevin Kuehn; 
  • Raeanne Moore; 
  • Katherine T. Foster; 
  • Colin Depp

ABSTRACT

Background:

Suicidal thoughts and behaviors (SITBs) are heterogeneous in their causes and course, yet most interventions rely on nomothetic, one-size-fits-all models. Dialectical behavior therapy (DBT) is an evidence-based treatment for SITBs, but its standard year-long format is resource-intensive and difficult to access. Ecological momentary assessment (EMA) combined with idiographic (person-specific) statistical modeling offers a way to identify which emotion-regulation processes are driving an individual’s risk, and in turn to select the DBT skills most relevant for that person.

Objective:

This protocol describes the refinement (Aim 1) and preliminary evaluation (Aim 2) of PRECISE, an eight-week, EMA-informed, idiographically tailored adjunctive treatment for adults with active suicidal ideation.

Methods:

In Aim 1, an existing PRECISE treatment manual and clinician dashboard will be iteratively refined with a mentorship/advisory panel and tested for feasibility and acceptability in a small, randomized pilot (N = 10; n = 5 per arm), comparing high- and low-intensity personalization schedules. In Aim 2, sixty adults with active suicidal ideation will be randomized to a high-intensity (weekly idiographic model updates across all eight EMA-monitored weeks) or low-intensity (single idiographic model generated after an initial two-week EMA burst) version of PRECISE. Both arms receive coach-delivered DBT skills selected according to each participant’s idiographic model, generated using the Group Iterative Multiple Model Estimation (GIMME) algorithm. Primary outcomes include usability, retention, EMA adherence, acceptability, and fidelity; secondary/exploratory analyses will examine trajectories of suicidal ideation and a within-person mediation model linking emotion regulation to SITBs.

Results:

This trial (ClinicalTrials.gov NCT06809348) was first posted on February 5, 2025, and enrollment began on November 14, 2025. The study is currently recruiting. Estimated total enrollment across Aim 1 and Aim 2 is 70 participants. Primary and final data collection are anticipated to be complete by March 2030.

Conclusions:

PRECISE is, to our knowledge, the first idiographically personalized, EMA-informed adjunctive treatment developed specifically for SITBs. This trial will provide feasibility, acceptability, and preliminary efficacy data to inform a subsequent fully powered efficacy trial. Clinical Trial: ClinicalTrials.gov NCT06809348; https://clinicaltrials.gov/study/NCT06809348


 Citation

Please cite as:

Kuehn K, Moore R, Foster KT, Depp C

Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial

JMIR Res Protoc 2026;15:e109277

DOI: 10.2196/109277

PMID: 43050679

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.